Intermedin Is a Calcitonin/Calcitonin Gene-related Peptide Family Peptide Acting through the Calcitonin Receptor-like Receptor/Receptor Activity-modifying Protein Receptor Complexes
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Calcitonin, calcitonin gene-related peptide (CGRP), adrenomedullin (ADM), and amylin belong to a unique group of peptide hormones important for homeostasis in diverse tissues. Calcitonin is essential for calcium balance, whereas CGRP and ADM are important for neurotransmission and cardiovascular and respiratory regulation. Based on phylogenetic analysis, we identified intermedin as a novel member of the calcitonin/CGRP peptide family. Analysis of intermedin expression indicated that intermedin is expressed primarily in the pituitary and gastrointestinal tract. Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors and competed with labeled CGRP for binding to its receptors in these cells. In addition, treatment of 293T cells expressing recombinant calcitonin receptor-like receptor (CRLR) and one of the three receptor activity-modifying proteins (RAMPs) showed that a CRLR/RAMP receptor complex is required for intermedin signaling. In contrast to CGRP and ADM, which exhibited a preferential stimulation of CRLR when co-expressed with RAMP1 and RAMP2 or RAMP3, respectively, intermedin represents a nonselective agonist for the RAMP coreceptors. In vivo studies demonstrated that intermedin treatment led to blood pressure reduction in both normal and spontaneously hypertensive rats via interactions with the CRLR/RAMP receptor complexes. Furthermore, in vivo treatment in mice with intermedin led to suppression of gastric emptying activity and food intake. Thus, identification of intermedin as a novel member of the calcitonin/CGRP peptide family capable of signaling through CRLR/RAMP receptor complexes provides an additional player in the regulation of peripheral tissues by CRLR and will allow development of new therapeutic agents for pathologies associated with diverse vascular and gastrointestinal disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 2004, two groups discovered the mammalian gene ADM2, which encodes a peptide with high similarity to adrenomedullin, and was named intermedin or adrenomedullin 2 (177, 195).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [177]
In the citing paper
“Roh et al. found that, in the rat, intermedin is primarily expressed in the pituitary and gastrointestinal tract and showed that intraperitoneal administration of intermedin decreased blood pressure in both normal and spontaneously hypertensive rats (98, 177).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [177]
In the citing paper
“Later studies have shown that CRLR/RAMP complex also functions as receptor for intermedin, which binds in a nonselective manner to either of the three RAMPs/CRLR dimers (177).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [177]
Citations
Cites
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
Rosenfeld, M. G., Mermod, J.-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., & Evans, R. M. (1983) · Nature · doi:10.1038/304129a0 · Cited by 2,302
Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma
Kitamura, K., Kangawa, K., Kawamoto, M., Ichiki, Y., Nakamura, S., Matsuo, H., & Eto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1451 · Cited by 2,192
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Amara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S., & Evans, R. M. (1982) · Nature · doi:10.1038/298240a0 · Cited by 2,105
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804
Activation of Orphan Receptors by the Hormone Relaxin
Hsu, S. Y., Nakabayashi, K., Nishi, S., Kumagai, J., Kudo, M., Sherwood, O. D., & Hsueh, A. J. W. (2002) · Science · doi:10.1126/science.1065654 · Cited by 786
Self-citationHsu, S. Y., & Hsueh, A. J. W. (2001) · Nature Medicine · doi:10.1038/87936 · Cited by 650
Self-citationCloning and Characterization of cDNA Encoding a Precursor for Human Adrenomedullin
Kitamura, K., Sakata, J., Kangawa, K., Kojima, M., Matsuo, H., & Eto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1881 · Cited by 605
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Research works printed but not linked: 7
- Copp, 1994, Clin. Investig. Med., 17, 268
- Mulder, 2000, Am. J. Physiol., 278, E684
- Chiba, 1989, Am. J. Physiol., 256, E331
- Eguchi, 1994, Endocrinology, 135, 2454, 10.1210/endo.135.6.7988431 · doi:10.1210/endo.135.6.7988431 · Paper page
- Reidelberger, 2002, Am. J. Physiol., 282, R1395
- Hsu, 2002, Mol. Endocrinol., 16, 1538, 10.1210/mend.16.7.0871 · doi:10.1210/mend.16.7.0871 · Paper page
- Meeran, 1997, J. Clin. Endocrinol. Metab., 82, 95
Cited by
Items 101–200 of 446
Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress
Hagiwara, M., Bledsoe, G., Yang, Z., SMITH, R. S., Chao, L., & Chao, J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90427.2008 · Cited by 41
“INTERMEDIN (IMD; also known as adrenomedullin-2) is a newly discovered peptide that belongs to the calcitonin/calcitonin gene-related peptide (CGRP) family, which includes calcitonin, CGRP, amylin, and adrenomedullin (36, 40).”
BackgroundZhao, L., Peng, D.-Q., Zhang, J., Song, J.-Q., Teng, X., Yu, Y.-R., Tang, C., & Qi, Y. (2012) · Peptides · doi:10.1016/j.peptides.2011.12.016 · Cited by 42
Adrenomedullin-RAMP2 System in Vascular Endothelial Cells
Koyama, T., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., & Shindo, T. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.29967 · Cited by 42
Intermedin Attenuates LPS-induced Inflammation in the Rat Testis
Li, L., Ma, P., Liu, Y., Huang, C. Y., Wai‐Sum, O., Tang, F., & Zhang, J. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065278 · Cited by 41
“It was independently cloned by two groups [6,7] and was shown to be expressed in the vasculature and a variety of tissues in other organs including the stomach, kidney, pituitary and placenta [6,7].”
BackgroundInfluentialFujisawa, Y., Nagai, Y., Miyatake, A., Miura, K., Shokoji, T., Nishiyama, A., Kimura, S., & Abe, Y. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00461.2005 · Cited by 44
“At the same time, a novel calcitonin/ CGRP family member, IMD, was identified (23).”
BackgroundInfluentialWang, Y., Li, C., Liu, Z., Shi, T., Wang, Q., Li, D., Wu, Y. L., Han, J., Guo, S., Tang, B., et al. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-67 · Cited by 40
“The key proteins in this pathway, such as adrenergic, angiotensin, and calcitonin receptor-like neurotensin receptors, are closely related to cardiac function [27-29].”
BackgroundCurrent understanding of the structure and function of family B GPCRs to design novel drugs
Karageorgos, V., Venihaki, M., Sakellaris, S., Pardalos, M., Kontakis, G. M., Matsoukas, M., Gravanis, A., Margioris, A. N., & Liapakis, G. (2018) · HORMONES · doi:10.1007/s42000-018-0009-5 · Cited by 45
Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA
Dai, X.-Y., Cai, Y., Sun, W., Ding, Y., Wang, W., Kong, W., Tang, C., Zhu, Y., Xu, M., & Wang, X. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt254 · Cited by 40
“IMD (also named adrenomedullin 2) was identified in 2004 by two independent research groups using genomic screens.(4,5) IMD binds non-selectively to both CGRP and adrenomedullin receptors(4) and plays pivotal roles in maintaining cardiovascular function and homoeostasis.”
BackgroundIntermedin1-53 activates l-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas
Yang, J., Pan, C., Jia, Y.-X., Zhang, J., Zhao, J., Pang, Y.-Z., Yang, J., Tang, C., & Qi, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.010 · Cited by 40
Intermedin Functions as a Pituitary Paracrine Factor Regulating Prolactin Release
Chang, C. L., Roh, J., Park, J., Klein, C., Cushman, N., Haberberger, R. V., & Hsu, S. Y. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0191 · Cited by 40
Self-citationYang, J., Qi, Y., Jia, Y.-X., Pan, C., Zhao, J., Yang, J., Chang, J., & Tang, C. (2004) · Peptides · doi:10.1016/j.peptides.2004.10.025 · Cited by 39
Zhang, H., Zhang, S.-Y., Jiang, C., Li, Y., Xu, G., Xu, M., & Wang, X. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.2 · Cited by 40
Vázquez, R., Riveiro, M. E., Berenguer‐Daizé, C., O’Kane, A. A., Gormley, J. A., Touzelet, O., Rezaï, K., Békradda, M., & Ouafik, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.589218 · Cited by 41
“also reported other two further alternative cuts able to generate 40- or 47-amino acid versions of the hormone (72).”
BackgroundInfluentialZhang, W., Wang, L., Xiao, F., Wei, Y., Ke, W., & Xin, H.-B. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300185 · Cited by 38
“IMD Signaled Through CRLR/RAMP2 Receptor Complex It has been reported that IMD was a nonselective agonist for CRLR/RAMP1, 2, or 3 receptor complexes.(2) However, RT-PCR analysis showed that only RAMP2, but not RAMP1 or RAMP3, was expressed in HUVECs (Figure 3G), which suggested that IMD may play its vascular remodelin…”
BackgroundMethodInfluentialKatafuchi, T., Yasue, H., Osaki, T., & Minamino, N. (2009) · Peptides · doi:10.1016/j.peptides.2009.06.012 · Cited by 37
Intermedin Enlarges the Vascular Lumen by Inducing the Quiescent Endothelial Cell Proliferation
Wang, L., Xiao, F., Kong, L., Wang, D., Li, H., Wei, Y., Chun, T., Zhao, H., Zhang, T., Cao, G., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310317 · Cited by 37
Increased Expression of Adrenomedullin 2/Intermedin in Rat Hearts with Congestive Heart Failure
Hirose, T., Totsune, K., Mori, N., Morimoto, R., Hashimoto, M., 中繁由紀子, Metoki, H., Asayama, K., Kikuya, M., Ohkubo, T., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.06.020 · Cited by 37
“Intravenous injection of AM2/IMD decreased arterial blood pressure [1,3,8], and this effect was partially blocked with CGRP and AM receptor antagonists [1].”
BackgroundResultInfluentialJulián, M., Cacho, M., García, M. A., Martín‐Santamaría, S., de Pascual‐Teresa, B., Ramos, A., Martínez, A., & Cuttitta, F. F. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.10.016 · Cited by 43
G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes
Roux, B. T., & Cottrell, G. S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011112 · Cited by 40
“Although, the highest affinity receptor observed for ADM2 is AM 2 receptors [116].”
Dong, Y.-L., Reddy, D. M., Green, K. E., Chauhan, M., Wang, H.-Q., Nagamani, M., Hankins, G. D. V., & Yallampalli, C. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.106.059089 · Cited by 40
“Coexpression of CALCRL with RAMP1 forms a CALCA receptor, whereas RAMP2 or RAMP3 produces an ADM receptor, and CALCRL with either of the three RAMPs mediates ADM 2 signaling [15].”
Zhang, S.-Y., Lv, Y., Zhang, H., Gao, S., Wang, T., Feng, J., Wang, Y., Liu, G., Xu, M.-J., Wang, X., et al. (2016) · Diabetes · doi:10.2337/db15-1626 · Cited by 36
“CRLR/RAMP1, as a G-protein–coupled receptor complex, increased the cellular cAMP level (Fig.”
BackgroundInfluentialIntermedin1–53 protects the heart against isoproterenol-induced ischemic injury in rats
Jia, Y.-X., Yang, J., Pan, C., Geng, B., Zhang, J., Xiao, Y., Zhao, J., Gerns, H., Yang, J., Chang, J., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.054 · Cited by 37
Chauhan, M., Ross, G. R., Yallampalli, U., & Yallampalli, C. (2007) · Endocrinology · doi:10.1210/en.2006-1105 · Cited by 37
Hashimoto, H., Hyodo, S., Kawasaki, M., Mera, T., Chen, L., Soya, A., Saito, T., Fujihara, H., Higuchi, T., Takei, Y., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00042.2005 · Cited by 37
“Previous studies have reported that AM2 activates a cAMP-dependent pathway via complexes of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMPs) with CGRP and AM (20, 32).”
BackgroundGrieco, P., & Gomez-Monterrey, I. M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.021 · Cited by 37
Chauhan, M., Yallampalli, U., Reed, L. C., & Yallampalli, C. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.106.053322 · Cited by 36
“Peripherally administered ADM2 exhibits potent hypotensive effects and has suppressive effects on gastric emptying activities and on food and water intake [1].”
BackgroundInfluentialPang, Y., Li, Y., Lv, Y., Sun, L., Zhang, S., Li, Y., Wang, Y., Liu, C., Xu, M., Wang, X., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.702654 · Cited by 39
“Intermedin (IMD),(3) also known as adrenomedullin 2 (AM2), is a 53-amino acid peptide belonging to the calcitonin generelated peptide/calcitonin family (1, 2).”
BackgroundCottrell, G. S., Alemi, F., Kirkland, J. G., Grady, E. F., Corvera, C. U., & Bhargava, A. (2012) · Peptides · doi:10.1016/j.peptides.2012.03.020 · Cited by 40
Adrenomedullin 2 protects rat cerebral endothelial cells from oxidative damage in vitro
Chen, L., Kis, B., Hashimoto, H., Busija, D. W., Takei, Y., Yamashita, H., & Ueta, Y. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.128 · Cited by 35
Kandilci, H. B., Gümüşel, B., Wasserman, A., Witriol, N., & Lippton, H. L. (2006) · Peptides · doi:10.1016/j.peptides.2005.10.024 · Cited by 35
Robinson, S. D., Aitken, J. F., Bailey, R. J., Poyner, D. R., & Hay, D. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156448 · Cited by 34
“It has been reported that AM2 was a nonselective agonist at the three CL/RAMP complexes (Roh et al., 2004), but recent evidence suggests that AM2 can show higher affinity for CL/RAMP3 compared with CL/RAMP1 (Qi et al.”
BackgroundIntermedin/adrenomedullin2: an autocrine/paracrine factor in vascular homeostasis and disease
Ni, X.-Q., Zhang, J., Tang, C., & Qi, Y. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4701-7 · Cited by 34
Hemodynamic, Hormonal, and Renal Actions of Adrenomedullin-2 in Normal Conscious Sheep
Charles, C. J., Rademaker, M. T., & Richards, M. (2006) · Endocrinology · doi:10.1210/en.2005-1403 · Cited by 34
Intermedin1-53 attenuates aging-associated vascular calcification in rats by upregulating sirtuin 1
Chen, Y., Zhang, L., Ren, J.-L., Zhang, Y.-R., Wu, N., Jia, M.-Z., Yu, Y.-R., Ning, Z., Tang, C., & Qi, Y. (2020) · Aging · doi:10.18632/aging.102934 · Cited by 33
Adrenomedullin: Not Just Another Gastrointestinal Peptide
Martínez-Herrero, S., & Martínez, A. (2022) · Biomolecules · doi:10.3390/biom12020156 · Cited by 36
“Treatment of the tumors with anti-AM antibodies or AM22–52 (a fragment of the peptide that blocks the binding of the hormone to its receptor) also reduced tumor growth and vascularization and increased tumor apoptosis [129].”
BackgroundCalcitonin Gene Related Family Peptides: Importance in Normal Placental and Fetal Development
Yallampalli, C., Chauhan, M., Endsley, J. J., & Sathishkumar, K. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1031-1_20 · Cited by 35
“Although these peptides have little sequence homology, they share similar secondary structure consisting of an amino acid ring structure formed by a single disulfi de bond and an amidated carboxyl terminus [ 1 , 2 ].”
BackgroundInfluentialAdrenomedullin 2/Intermedin in the Hypothalamo–Pituitary–Adrenal Axis
Takahashi, K., Morimoto, R., Hirose, T., Satoh, F., & Totsune, K. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9413-2 · Cited by 33
“…Hypothalamus Taylor et al. (2005) Stomach Anterior lobe of pituitary Posterior lobe of pituitary Heart Human (GI tract) RT-PCR Stomach Esophagus Roh et al. (2004) Jejunum Ileum Colon Rectum Human (Brain, pituitary, adrenal, heart, and kidney) RIA, ICC Pituitary Kidney Hypothalamus and other…”
BackgroundMethodInfluentialHong, Y., Liu, Y., Chabot, J., Fournier, A., & Quirion, R. (2009) · Pain · doi:10.1016/j.pain.2009.07.015 · Cited by 35
“The calcitonin family of peptides consists of two calcitonin gene-related peptides (a-CGRP and b-CGRP), calcitonin, amylin, adrenomedullin (AM) [43,60], intermedin (also called AM2) [46] and calcitonin receptor-stimulating peptide 1, 2 and 3 [22,23].”
BackgroundWatkins, H. A., Walker, C. S., Ly, K. N., Bailey, R. J., Barwell, J., Poyner, D. R., & Hay, D. L. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12508 · Cited by 34
“AM2 is a more recently discovered member of the AM family (Roh et al., 2004; Takei et al., 2004a,b) and, along with AM, has extensive effects on the CVS including vasodilatation, cardioprotection, modulation of vascular tone and stimulation of angiogenesis (Hinson et al., 2000; Fujisawa et al.,…”
BackgroundZhou, Y., Sun, H., Chen, D., Liu, T., Han, Y., Wang, J., Tang, C., Kang, Y., & Zhu, G. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01681 · Cited by 33
“330 Intermedin (IMD) or adrenomedullin (AM) 2 is a member of the calcitonin/calcitonin gene–related peptide (CGRP) family discovered in 2004.(1) Unlike other members of this family, no unique receptor has yet been identified for IMD.”
BackgroundNi, X.-Q., Lu, W., Zhang, J., Zhu, Q., Ren, J.-L., Yu, Y.-R., Liu, X., Wang, X., Han, M., Jing, Q., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1657-6 · Cited by 35
“IMD belongs to the calcitonin/calcitonin gene-related peptide (CGRP) family [12] and IMD1-53 may be the main active fragment [14].”
BackgroundGonzález‐Hernández, A., Marichal‐Cancino, B. A., Lozano‐Cuenca, J., López‐Canales, J. S., Muñoz‐Islas, E., Ramirez-Rosas, M. B., & Villalón, C. M. (2016) · BioMed Research International · doi:10.1155/2016/2056786 · Cited by 36
Martínez-Álvarez, R., Volkoff, H., Muñoz‐Cueto, J. A., & Delgado, M. J. (2008) · Peptides · doi:10.1016/j.peptides.2008.04.013 · Cited by 34
“[34] Roh J, Chang CL, Bhalla A, Klein C, Hsu SY.”
BackgroundInfluentialIntermedin 1–53 in central nervous system elevates arterial blood pressure in rats
Ren, Y., Yang, J., Zhang, J., Pan, C., Yang, J., Zhao, J., Pang, Y.-Z., Tang, C., & Qi, Y. (2005) · Peptides · doi:10.1016/j.peptides.2005.06.011 · Cited by 31
Kuwasako, K., Kitamura, K., Nagata, S., Hikosaka, T., & Kato, J. (2010) · Peptides · doi:10.1016/j.peptides.2010.10.005 · Cited by 30
Takei, Y., Kawakoshi, A., Tsukada, T., Yuge, S., Ogoshi, M., Inoue, K., Hyodo, S., Bannai, H., & Miyano, S. (2006) · Journal of Experimental Zoology Part A Comparative Experimental Biology · doi:10.1002/jez.a.309 · Cited by 32
Grossini, E., Molinari, C. G., Mary, D., Uberti, F., Caimmi, P. P., & Vacca, G. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00569.2009 · Cited by 30
“Finally, pretreatment of the pigs with CGRP8–37 at doses similar to the ones that in anesthetized rats was found to inhibit the hypotension caused by IMD1–47 (45) and completely prevented the increase of coronary blood flow caused by IMD1–47.”
BackgroundResultInfluentialGarcía‐Ponce, A., Chánez-Paredes, S. D., Castro-Ochoa, K. F., & Schnoor, M. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1228439 · Cited by 34
“ADM predominantly signals through CRLR/ RAMP2 and CRLR/RAMP3,(62) whereas IMD primarily signals via CRLR/RAMP1 or CRLR/RAMP3, and to a lesser extent also via CRLR/RAMP2.(44) Given that TISSUE BARRIERS e1228439-7”
BackgroundKinins and Neuro-osteogenic Factors
Lerner, U. H., Persson, E., & Lundberg, P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00063-x · Cited by 31
Intermedin protects HUVECs from ischemia reperfusion injury via Wnt/β-catenin signaling pathway
Wang, Y., Wu, Z.-J., Tian, J., Mi, Y., Ren, X., Kang, J., Zhang, W., Zhou, X., Wang, G., & Li, R. (2019) · Renal Failure · doi:10.1080/0886022x.2019.1587468 · Cited by 30
“Recent studies suggested that IMD stimulates cAMP/PKA signaling [10].”
BackgroundMethodIntermedin Reduces Oxidative Stress and Apoptosis in Ventilator-Induced Lung Injury via JAK2/STAT3
Fan, S., He, J., Yang, Y., & Wang, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.817874 · Cited by 31
Intermedin is upregulated and has protective roles in a mouse ischemia/reperfusion model
Zhang, H., Jiang, W., Liu, J., Li, Y., Chen, C., Xin, H., & Huang, D. (2009) · Hypertension Research · doi:10.1038/hr.2009.120 · Cited by 28
“7 Intermedin (IMD) was identified as a novel calcitoninscalcitonin gene-related peptide (CGRP) family member based on the analysis of multiple vertebrate genomes”
BackgroundKovaleva, I. E., Garaeva, A. A., Chumakov, P. M., & Evstafieva, A. G. (2016) · Gene · doi:10.1016/j.gene.2016.06.037 · Cited by 28
“The family includes calcitonin, calcitonin gene-related peptide (CGRP), amylin, and adrenomedullin (ADM) and play important roles in maintaining the body homeostasis (Roh et al., 2004).”
BackgroundInfluentialAdrenomedullin regulates intestinal physiology and pathophysiology
Martínez-Herrero, S., & Martínez, A. (2016) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2016.02.004 · Cited by 30
Regulation of Oocyte and Cumulus Cell Interactions by Intermedin/Adrenomedullin 2
Chang, C. L., Wang, H., Soong, Y., Huang, S. Y., Pai, S. Y., & Hsu, S. Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297358 · Cited by 28
Self-citationLafont, A.-G., Dufour, S., & Fouchereau‐Péron, M. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.01.027 · Cited by 28
Hashimoto, H., Hyodo, S., Kawasaki, M., Shibata, M., Saito, T., Suzuki, H., Otsubo, H., Yokoyama, T., Fujihara, H., Higuchi, T., et al. (2007) · Peptides · doi:10.1016/j.peptides.2007.02.007 · Cited by 31
Role of calcitonin gene-related peptide in energy metabolism
Lima, W. G., Marques‐Oliveira, G. H., da Silva, T. M., & Chaves, V. E. (2017) · Endocrine · doi:10.1007/s12020-017-1404-4 · Cited by 27
“The calcitonin family of peptides includes, beyond calcitonin, two isoforms of calcitonin gene-related peptide (CGRP) [1, 2], named as αCGRP and βCGRP [3], amylin (AMY) or islet amyloid polypeptide [4], adrenomedullin (AM) [5] and AM2 or intermedin [6, 7].”
BackgroundHong, Y., Wang, D., Chabot, J., Ma, W., Chen, P., & Quirion, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0306-10.2010 · Cited by 27
Morimoto, R., Satoh, F., Murakami, O., Hirose, T., Totsune, K., Imai, Y., Arai, Y., SUZUKI, T. A., Sasano, H., Ito, S., et al. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0103 · Cited by 27
“AM2/IMD may have a similar mitogenic action because AM2/IMD shares its receptor systems with AM (Roh et al. 2004).”
BackgroundInfluentialAslam, M., Gündüz, D., Schuler, D., Li, L., Sharifpanah, F., Sedding, D., Piper, H. M., & Noll, T. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr213 · Cited by 27
“Intermedin (IMD) is a novel member of the calcitonin gene-related peptide (CGRP) superfamily, having 33% sequence homology with adrenomedullin (AM).(8) Intermedin is expressed in a variety of tissues and organs, including brain, heart and endothelium.”
BackgroundMethodResultInfluentialTakahashi, K., Hirose, T., Mori, N., Morimoto, R., Kohzuki, M., Imai, Y., & Totsune, K. (2009) · Peptides · doi:10.1016/j.peptides.2009.05.018 · Cited by 27
“AM preferentially interacts with CRLR/RAMP 2 or 3, and CGRP with CRLR/RAMP 1, whereas AM2/IMD interacts with CRLR/RAMP 1, 2, or 3 nonselectively [94].”
Adrenomedullin: a new and promising target for drug discovery
García, M. A., Martín‐Santamaría, S., de Pascual‐Teresa, B., Ramos, A., Julián, M., & Martínez, A. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.2.303 · Cited by 29
“AM has been classified as a member of the calcitonin/calcitonin gene-related peptide (CGRP)/amylin/AM superfamily [4].”
BackgroundGranholm, S., Henning, P., & Lerner, U. H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23256 · Cited by 26
“IMD/ADM2 has been found to exert several physiological/pharmacological responses similar to CGRP and ADM, including decreased blood pressure, inhibition of cardiac function [Roh et al., 2004; Pan et al., 2005] and suppression of gastric emptying and food intake [Roh et al.”
BackgroundMethodInfluentialIntermedin1–53 inhibits rat cardiac fibroblast activation induced by angiotensin II
Yang, J. H., Cai, Y., Duan, X. H., Ma, C. G., Wang, X., Tang, C., & Qi, Y. F. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.05.012 · Cited by 26
Potential role of intermedin/adrenomedullin 2 in early embryonic development in rats
Chauhan, M., Elkins, R., Balakrishnan, M. P., & Yallampalli, C. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.05.011 · Cited by 26
“IMD is abundantly expressed in rat ovary, uterus, and placenta, along with its expression in other tissues such as brain, heart, and pituitary gland [19,20].”
Intermedin protects against myocardial ischemia-reperfusion injury in hyperlipidemia rats
Yang, S.-G., Liu, J., & Li, C. X. (2014) · Genetics and Molecular Research · doi:10.4238/2014.october.20.7 · Cited by 26
“Intermedin (IMD), also known as adrenomedullin 2, is a newly discovered peptide that belongs to the calcitonin gene-related peptide (CGRP) superfamily (Roh et al., 2004).”
BackgroundZhu, Q., Ni, X.-Q., Lu, W., Zhang, J., Ren, J.-L., Wu, D., Chen, Y., Zhang, L., Yu, Y.-R., Tang, C., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.011 · Cited by 26
“biological functions than the other members because of its wider tissue distribution in the body and binding non-selectivity to all CRLR/RAMP complexes [29].”
BackgroundCORONARY VASODILATORY RESPONSE TO A NOVEL PEPTIDE, ADRENOMEDULLIN 2
Kobayashi, Y., Liu, Y., Gonda, T., & Takei, Y. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.04115.x · Cited by 26
Martínez-Álvarez, R., Volkoff, H., Muñoz‐Cueto, J. A., & Delgado, M. J. (2008) · Peptides · doi:10.1016/j.peptides.2008.12.015 · Cited by 28
“In mice, peripheral administration of IMD inhibits food intake and suppresses stomach emptying responses [32].”
BackgroundResultInfluentialTakei, Y., Hashimoto, H., Inoue, K., Osaki, T., Yoshizawa‐Kumagaye, K., Tsunemi, M., Watanabe, T. X., Ogoshi, M., Minamino, N., & Ueta, Y. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0541 · Cited by 28
“However, the potencyof AM2 for cAMP accumulation in CLR–RAMP was much lower than AM (Roh et al. 2004, Takei et al. 2004a), while its central actions are even greater than AM (Hashimoto et al. 2007).”
InfluentialPotent cardiovascular actions of homologous adrenomedullins in eels
Nobata, S., Ogoshi, M., & Takei, Y. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00707.2007 · Cited by 28
Roehrkasse, A. M., Booe, J. M., Lee, S. M., Warner, M. L., & Pioszak, A. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005062 · Cited by 25
“Adrenomedullin 2/intermedin (AM2/IMD)(2) is the newest member of the calcitonin peptide family, which also includes calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) (1, 2).”
BackgroundNi, X.-Q., Zhang, Y.-R., Jia, L., Lu, W., Zhu, Q., Ren, J.-L., Chen, Y., Zhang, L., Liu, X., Yu, Y.-R., et al. (2021) · Aging · doi:10.18632/aging.202436 · Cited by 29
“IMD is a vasoactive peptide that belongs to the calcitonin generelated peptide (CGRP) superfamily, discovered by Roh [18] and Takei [19] in 2004.”
BackgroundGPCR Genes Are Preferentially Retained after Whole Genome Duplication
Semyonov, J., Park, J., Chang, C. L., & Hsu, S. Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001903 · Cited by 27
“With the same approach that we used to identify nGPCR homologs and novel peptide hormones in earlier studies [53,54,55,56,57,58], we identified 118 human and 118 T.”
BackgroundMethodSelf-citationIntermedin ameliorates atherosclerosis in apoE null mice by modifying lipid profiles
Zhang, X., Gu, L., Chen, X., Wang, S., Deng, X., Liu, K., Lv, Z., Yang, R., He, S., Peng, Y., et al. (2012) · Peptides · doi:10.1016/j.peptides.2012.07.011 · Cited by 25
Müller-Redetzky, H., Kummer, W., Pfeil, U., Hellwig, K., Will, D., Paddenberg, R., Tabeling, C., Hippenstiel, S., Suttorp, N., & Witzenrath, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035832 · Cited by 25
“Previous studies suggested that IMD predominantly signals through receptor complexes composed of CRLR and RAMP2 or 3 [8,9].”
BackgroundGuo, X., Schmitz, J. C., Kenney, B. C., Uchio, E., Kulkarni, S., & Cha, C. H. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02341.x · Cited by 26
Zhu, Y., Wu, H., Wu, Y., Zhang, J., Peng, X., Zang, J., Xiang, X., Liu, L., & Li, T. (2016) · Shock · doi:10.1097/shk.0000000000000639 · Cited by 25
“(9), and confirmed to be distributed in the hypothalamus, heart, and kidneys (10).”
BackgroundBlockade of adrenomedullin receptors reverses morphine tolerance and its neurochemical mechanisms
Wang, D., Chen, P., Li, Q., Quirion, R., & Hong, Y. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.046 · Cited by 25
Bell, D., Zhao, Y., McCoy, F. P. G., Devine, A. B., & McDermott, B. J. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000107513 · Cited by 28
Wunder, F., Rebmann, A., Geerts, A., & Kalthof, B. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.042283 · Cited by 26
“IMD, a novel member of this peptide family (Roh et al., 2004), activated both receptors with similar potencies.”
BackgroundInfluentialLi, P., Sun, H., Han, Y., Wang, J., Zhang, F., Tang, C., & Zhou, Y. (2013) · Peptides · doi:10.1016/j.peptides.2013.05.002 · Cited by 24
Pathophysiological function of oxytocin secreted by neuropeptides: A mini review
Hashimoto, H., Uezono, Y., & Ueta, Y. (2012) · Pathophysiology · doi:10.1016/j.pathophys.2012.07.005 · Cited by 28
“A similar 7-amino acid neuropeptide, adrenomedullin 2 (AM2), dentical to intermedin, was first isolated from pufferfish 101,102] and later from mammals [102,103] by the search n the genomic databases [101,102] (Fig.”
BackgroundEffects of adrenomedullin 2 on regional hemodynamics in conscious rats
Fujisawa, Y., Nagai, Y., Miyatake, A., Miura, K., Nishiyama, A., Kimura, S., & Abe, Y. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.043 · Cited by 24
Development of chimeric and bifunctional antagonists for CLR/RAMP receptors
Chang, C. L., & Hsu, S. Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216996 · Cited by 23
Self-citationContreras‐Duarte, S., Carvajal, L., Garchitorena, M. J., Subiabre, M., Fuenzalida, B., Cantin, C., Farías, M., & Leiva, A. (2020) · Nutrients · doi:10.3390/nu12020506 · Cited by 25
Qi, T., Ly, K. N., Poyner, D. R., Christopoulos, G., Sexton, P. M., & Hay, D. L. (2011) · Peptides · doi:10.1016/j.peptides.2011.03.004 · Cited by 24
Hay, D. L. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04703.x · Cited by 23
“68 With further study, the newly identified peptide AM 2 (intermedin) may be a useful addition in pharmacological studies.(81,82) As mentioned earlier, receptor component expression studies should be performed alongside pharmacology studies wherever possible to aid data interpretation.”
BackgroundQin, Y., Teng, X., He, J., Du, J., Tang, C., & Qi, Y. (2013) · Peptides · doi:10.1016/j.peptides.2013.01.011 · Cited by 22
Havemann, D., Balakrishnan, M. P., Borahay, M. A., Theiler, R. N., Jennings, K., Endsley, J. J., Phelps, J. Y., Hankins, G. D. V., Yallampalli, C., & Chauhan, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2172 · Cited by 22
Bell, D., Zhao, Y., Kelso, E. J., McHenry, E. M., Rush, L., Lamont, V., Nicholls, D., & McDermott, B. J. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00152.2005 · Cited by 24
Qiao, X., Wang, L., Wang, Y., Su, X., Qi, Y. A., Fan, Y., & Peng, Z. (2017) · Renal Failure · doi:10.1080/0886022x.2017.1361839 · Cited by 22
“Since IMD and ADM have similar biological actions [4], we hypothesized that IMD may suppress the production of ROS via NADPH oxidase Nox4 and cAMP-dependent mechanisms.”
BackgroundHuman Islet Response to Selected Type 1 Diabetes-Associated Bacteria: A Transcriptome-Based Study
Abdellatif, A. M., Smith, H. J., Harms, R. Z., & Sarvetnick, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02623 · Cited by 26
“peptide belonging to calcitonin family hormones (32), with its expression being upregulated in different stress conditions including endoplasmic reticulum (er) and oxidative stress (33, 34).”
BackgroundIntermedin (Adrenomedullin-2): a Potential Protective Role in Human Aortic Endothelial Cells
Pearson, L., Yandle, T. G., Nicholls, M. G., & Evans, J. J. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000204098 · Cited by 22
Ogoshi, M., Nobata, S., & Takei, Y. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90688.2008 · Cited by 27
Prevention of Bone Loss in a Model of Postmenopausal Osteoporosis through Adrenomedullin Inhibition
Martínez-Herrero, S., Larrayoz, I. M., Ochoa-Callejero, L., Fernández, L. J., Allueva, A., Ochoa, I., & Martínez, A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00280 · Cited by 21
“On the other hand, there may be a cross-reactivity of the kit’s AM antibody with other members of the peptide family, such as AM2 or intermedin, which shares a 28% overall sequence identity with AM (Roh et al., 2004).”
BackgroundVascular Calcification: In Vitro Models under the Magnifying Glass
Ceccherini, E., Cecchettini, A., Gisone, I., Persiani, E., Morales, M. A., & Vozzi, F. (2022) · Biomedicines · doi:10.3390/biomedicines10102491 · Cited by 23
Bell, D., Zhao, Y., McCoy, F. P. G., Devine, A. B., & McDermott, B. J. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000129633 · Cited by 21
Fang, A., Zhou, S., Su, X., Liu, C., Chen, X., Wan, Y., Lei, X., Xie, L., Jia, Y., Wang, W.-Z., et al. (2018) · Future Oncology · doi:10.2217/fon-2018-0296 · Cited by 21
Metadata
- Authors
- Roh, J., Chang, C. L., Bhalla, A., Klein, C., & Hsu, S. Y. T.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Hsu, Sheau Yu Teddy
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 279
- Issue
- 8
- Pages
- 7264-7274
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2044285853
- Cited by
- 443
- References
- 37
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 7 · 2023: 12 · 2022: 15 · 2021: 16 · 2020: 17 · 2019: 15 · 2018: 22 · 2017: 25 · 2016: 23 · 2015: 20 · 2014: 22 · 2013: 24 · 2012: 24
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6102 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- School of Medicine, Stanford University
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Keywords
- intermedin, calcitonin gene-related peptide, calcitonin, adrenomedullin, amylin, calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, RAMP3, cAMP signaling, blood pressure regulation, hypertension, gastric emptying, dietary intake, pituitary gland, gastrointestinal tract
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Base Sequence, Blood Pressure, Calcitonin, Cell Line, Cloning, Molecular, Dose-Response Relationship, Drug, Humans, Male, Mice, Inbred C57BL, Molecular Sequence Data, Peptides, Phylogeny, Protein Binding, Rats, Inbred SHR, Time Factors, Tissue Distribution, Transfection, Blotting, Northern, Signal Transduction, Calcitonin Gene-Related Peptide, Rats, Sprague-Dawley, Sequence Homology, Amino Acid, Receptors, Calcitonin Gene-Related Peptide, DNA, Complementary, Peptide Hormones, Cell Line, Tumor, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.